Cancer
Home to one of the nation’s leading early drug development programs, HonorHealth Research Institute offers more early phase cancer clinical trials than any other Arizona cancer center and is often the first site in the nation to evaluate a promising new therapy in a Phase I clinical trial.
In 2019, our researchers studied more than 70 new agents and conducted 100 cancer studies. Since 2015, HonorHealth Research Institute’s first-in-human clinical trials have been key to the FDA approval of at least two dozen new cancer treatments, including eight in 2019. These studies provide our community with early access to potential advances before they are available in routine practice.
Related Stories...
COVID-19
HonorHealth Research Institute quickly launched several clinical trials in response to the COVID-19 pandemic.
Read More
Heart and Vascular
HonorHealth Research Institute was first in the Southwest and second in the nation to implant an MRI-safe pacemaker.
Read More
Trauma
HonorHealth Research Institute researchers have investigated early detection of pneumonia linked to the use of a ventilator.
Read More
Advances in Immunotherapy
Thanks to the generosity of local philanthropists, physician-scientists at HonorHealth Research Institute are examining several different aspects of the body’s immune response to cancer and how they can be leveraged to improve the effectiveness of today’s standard chemotherapies.
Read More